High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke
Open Access
- 26 January 2011
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 31 (6), 1387-1393
- https://doi.org/10.1038/jcbfm.2011.4
Abstract
The capacity of the blood enzyme glutamate oxaloacetate transaminase (GOT) to remove glutamate from the brain by means of blood glutamate degradation has been shown in experimental models to be an efficient and novel neuroprotective tool against ischemic stroke; however, the beneficial effects of this enzyme should be tested in patients with stroke to validate these results. This study aims to investigate the association of GOT levels in blood with clinical outcome in patients with acute ischemic stroke. In two clinical independent studies, we found that patients with poor outcome show higher glutamate and lower GOT levels in blood at the time of admission. Lower GOT levels and higher glutamate levels were independently associated with poorer functional outcome at 3 months and higher infarct volume. These findings show a clear association between high blood glutamate levels and worse outcome and vice versa for GOT, presumably explained by the capacity of this enzyme to metabolize blood glutamate.Keywords
This publication has 21 references indexed in Scilit:
- Serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) levels in children and adolescents with intellectual disabilitiesResearch in Developmental Disabilities, 2010
- Homeostasis of glutamate in brain fluids: An accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologiesNeuroscience, 2009
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeThe New England Journal of Medicine, 2008
- Characteristics of 4 stroke scales for the detection of changes in clinical signs in the acute phase of strokeJournal Of Stroke & Cerebrovascular Diseases, 2001
- Na+-dependent Glutamate Transporters (EAAT1, EAAT2, and EAAT3) of the Blood-Brain BarrierOnline Journal of Public Health Informatics, 1999
- Assessment scales for the evaluation of stroke patientsJournal of Stroke and Cerebrovascular Diseases, 1998
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- An evaluation of the Waters Pico-Tag system for the amino-acid analysis of food materialsJournal of Automatic Chemistry, 1986
- Serum Glutamic Oxaloacetic Transaminase Activity in Human Acute Transmural Myocardial InfarctionScience, 1954